← Back to all articles

FDA Announces Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution Due to Contamination Concerns

By Adam J. Langino, Esq.

FDA Announces Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution Due to Contamination Concerns

The U.S. Food and Drug Administration has announced a voluntary nationwide recall involving Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, a veterinary product distributed for use in dogs, cats, and horses. The recall was initiated after concerns arose regarding microbial contamination, calling into question the sterility of certain product lots and the safety assurances provided to veterinarians and animal owners.

Veterinary products labeled as “sterile” occupy a distinct category of trust. Sterility is not a marketing preference—it is a fundamental safety representation, particularly for products used in wound care, surgical settings, and other situations where infection presents serious risks. When sterility cannot be reliably maintained, the consequences can extend well beyond a single product line.

What the FDA Has Reported About the Recall

According to the FDA, Neogen Corporation is recalling all lots within expiry of its HYCOAT® Hyaluronate Sodium Sterile Solution. The product is manufactured by a third‑party supplier and was distributed nationwide to veterinary professionals and animal health distributors.

The recall was prompted by findings of microbial contamination in certain product vials, meaning the recalled solution should no longer be considered sterile. The FDA has warned that contaminated vials may introduce infection risks if used on animals.

The agency has also reported that Neogen received adverse event reports in horses, particularly in connection with intra‑articular injections. While those injections were not consistent with the product’s labeled, intended use, the presence of contamination remains a serious concern regardless of how the product was ultimately applied in the field. The FDA has indicated that the investigation remains ongoing.

Why Sterility Failures Matter in Veterinary Products

Sterility is especially critical for veterinary products intended to manage wounds, burns, ulcers, or post‑surgical conditions. Animals receiving veterinary care cannot describe symptoms or discomfort in the same way humans can, and infections may progress before visible warning signs emerge.

When a product is represented as sterile but later found to be contaminated, the issue implicates broader questions of manufacturing controls, supplier oversight, quality assurance testing, and post‑market surveillance. These safeguards exist precisely to prevent contaminated products from reaching veterinarians and animal owners in the first place.

Failures in sterility assurance can expose animals to avoidable harm and place veterinarians in the position of unknowingly relying on compromised products.

Relevance for North Carolina’s Equine Communities

This recall has particular relevance in North Carolina, which is home to several regions with dense equine populations and active veterinary practices.

In Moore County, communities such as Southern Pines and Pinehurst are nationally recognized for horse farms, training facilities, and competitive riding operations. Veterinary wound‑care and post‑procedure products are routinely used in these environments, making sterility issues particularly consequential.

Polk County, including Tryon, Columbus, and Mill Spring, is widely regarded as one of the state’s leading counties for horses per capita and is home to the Tryon International Equestrian Center. The concentration of equine activity in this region increases the likelihood that recalled veterinary products may already be present in barns, clinics, or training facilities.

In Franklin County, which serves as a major regional center for horse ownership in eastern North Carolina, veterinarians and farm operators regularly depend on sterile solutions as part of routine animal care. Contamination concerns tied to recalled products have the potential to affect a broad segment of the equine community.

Guilford County, part of the Central Piedmont, also maintains a significant equine presence, with a mix of professional veterinary practices, boarding operations, and private farms. For these communities, recall notices involving sterility failures are not abstract regulatory events—they are matters of day‑to‑day operational and animal safety importance.

Corporate Accountability and Quality Control

Situations like this underscore the importance of corporate accountability in the veterinary supply chain. When a company distributes products intended to meet sterility standards, responsibility extends beyond labeling and marketing to include:

  • Supplier selection and oversight

  • Batch testing and microbial controls

  • Clear communication with distributors and veterinarians

  • Prompt corrective action when issues arise

The recall process itself is an essential safety mechanism, but recalls also raise questions about whether contamination risks could have been identified earlier through stronger quality assurance measures.

What Veterinarians and Farm Operators Should Consider

Veterinarians and equine professionals in North Carolina should take steps to review current inventories, confirm whether affected lots are present, and follow recall instructions regarding quarantine and discontinuation of use. Any suspected adverse events should be documented and reported through appropriate regulatory channels.

At a broader level, recalls involving sterility failures highlight why diligence in product sourcing and manufacturer accountability remains critical in veterinary medicine.

Call to Action

Langino Law represents families and professionals affected by failures in product safety and manufacturing accountability. Matters involving contaminated products—whether in medical, veterinary, or consumer settings—raise serious legal and ethical questions about what companies should have done differently to prevent harm.

Anyone with concerns related to recalled or contaminated products is encouraged to speak with experienced counsel. Langino Law offers free consultations at 888‑254‑3521, or by contacting the firm through the website at https://www.langinolaw.com/contact.

U.S. Food and Drug Administration. Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution. FDA Safety Recalls and Alerts, Jan. 29, 2026.